𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ifosfamide combination chemotherapy in advanced breast cancer

✍ Scribed by Hans Schmid; Manfred Kaufmann; Eva-Maria Grischke; Gunther Bastert

Publisher
Springer
Year
1990
Tongue
English
Weight
249 KB
Volume
26
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.

Cisplatin plus VP-16 combination chemoth
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer
✍ Dr. Fikri IΓ§li; Nazan GΓΌunel; Dilek DinΓ§lol; Handan KaraoΗ§uz; Ahmet Demirkazik πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

Twenty-nine patients with advanced refractory breast cancer were treated with cisplatin 20 mg/m2/d and VP-16 100 mg/d for 5 days every 3 4 weeks. Ten patients received mitomycin C 10 mg/m2 every 6 weeks additionally. Partial response was obtained in 10 of 26 evaluable patients (38%). The response ra

Combination chemotherapy for advanced br
Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin
✍ Gerard T. Kennealey; Barry Boston; Malcolm S. Mitchell; Mary Kathryn Knobf; Samu πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 518 KB

Forty-eight women with advanced metastatic carcinoma of the breast were treated with one of two combination chemotherapy regimens: 1) adriamycin and cyclophosphamide or 2) adriamycin, cyclophosphamide, methotrexate and 5-fluorouracil. The response rate in the two-drug treatment group was 50% and in